A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for...

9
A sub-network of signaling protein complexes in Alopecia Areata may provide new molecular candidates for pharmacologic targeting Adam G. Schrum, PhD Assistant Professor of Immunology Mayo Clinic College of Medicine

Transcript of A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for...

Page 1: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

A sub-network of signaling protein complexes in

Alopecia Areata may provide new molecular

candidates for pharmacologic targeting

Adam G. Schrum, PhD

Assistant Professor of Immunology

Mayo Clinic College of Medicine

Page 2: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

CD28 a b

CD8

SLAP 130

TCR

a b CD3

e g

z z

CD4

CBP

CSK

CD45

LCK

FYN Zap70

Calcineurin NFATc

Calmodulin Ca2+

Bcl-10

CD3

de

IKKa

IKKb

IKKg TBK1

IKKe

TANK

IkB

NFkB

MALT1

GRB2

SOS1

RAS

RAF1

MEK1

ERK1/ERK2

DOK1

DOK2

SHIP1

GADS

SLP-76

Nck

PAK

WASP

WIP

F-actin

ARP2/3

ITK

CDC42 RAC1

MEKK1

JNKK1

JNK1

SHP1/2

CARMA1 LAT PLCg CpA

PKCq VAV

PI3K

AKT

PKCa

PKCb

Cbl-b

B7.1/2 MHC

1 2

APC MHC

1

T cell

THEMIS CD6

Do different signals through TCR affect

immunologic tolerance and AA?

Qualitative

Quantitative

Kinetic

What could be

“different” ?

Page 3: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

Responders: Jurkat

APCs: Raji

+/- SEE, 5 min

PiSCES: Proteins in Shared Complexes detected by Exposed Surface epitopes:

a multiplex matrix analysis to assess PPI network signatures

Smith SEP, Neier SC, et al., Aug 2, 2016 Science Signaling (AAAS)

Page 4: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

PiSCES network analysis &

visualization

Responders: Jurkat

APCs: Raji

+/- SEE, 5 min

SEE / null, 5 min SEE CD28+ / SEE CD28–, 5 min

Page 5: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

Subject T cells

(millions) %CD4

SP %CD8

SP %CLA+CCR4+ Age Sex

aa1 2 20.9 56.9 12.9 29 m

aa2 3 65.4 28 74.2 50 f

aa3 8.4 14.7 76.3 17.4 50 f

aa4 3.87 88.9 8.7 44.5 81 f

aa5 1.32 21.6 59.3 21.7 39 f

aa6 1.58 85.1 7.7 71.5 41 f

aa7 1.58 69.3 25 16.6 59 m

cntl1 1.5 82.9 6.1 24.4 51 m

cntl2 1.6 78 17.9 50.5 77 m

cntl3 6.8 91.8 5.1 84.2 51 m

cntl4 6.2 98.1 0.3 79.1 76 m

cntl5 2.8 85.9 12.3 59 89 f

T cells from volunteer patient punch-biopsies

Page 6: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

Overall similar response

pattern between Control

and AA patient T cells to

anti-CD3/anti-CD28

stimulation

Page 7: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

PiSCES data distinguishes AA from Control patient T cells,

and suggests increased basal TCR signaling in AA

AA > Ctrl

Ctrl > AA

Difference in basal levels

Page 8: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

ITK

Thy1

Fyb

TCR

a b

z z

LCK Zap70

CD3

de

GADS

Nck

SLP-76

LAT VAV

plasma membrane

GRB2

SOS1

LAT

PKCq

PLCg Fyn

Zap70

CD3

e g

SKAP55 Integrin activation

Cell adhesion

Ras-Raf-ERK Differentiation

Clonal expansion

AA > CtrlCtrl > AA

Upon exogenous stimulation, PiSCES network activity

suggests disease-associated signaling profile in

Alopecia Areata patients

Page 9: A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular Candidates for Pharmacologic Targeting

Acknowledgements

Schrum Lab

• Stephen E.P. Smith, PhD

(currently Assistant

Professor, U. WA,

Seattle)

• Steven Neier

• Brendan Reed

• Tessa Davis

Diana Gil, PhD

• Alejandro Ferrer, PhD

• Robert Stiles

Collaborators

• Claudia Neuhauser, PhD (U. MN, Comput. Biol.)

• Jeanette Eckel-Passow, PhD (Mayo Biostatisitics)

• Jason P. Sinnwell (Mayo Biostatistics)

• Gabriel Sciallis, MD (Mayo Dermatology)

• Carrie Wieland, MD (Mayo Dermatology)

• Shelly Torgerson, MD/PhD (Mayo Dermatology)

Funding partners

• R01 NIGMS

• Mr. Bernie Fineman (Mayo Benefactor)